Two‐drug fixed‐dose combinations of blood pressure‐lowering drugs as WHO essential medicines: An overview of efficacy, safety, and cost
Open Access
- 20 August 2020
- journal article
- review article
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 22 (10) , 1769-1779
Abstract
Cardiovascular diseases (CVD) are the world's leading cause of death. High blood pressure (BP) is the leading global risk factor for all‐cause preventable morbidity and mortality. Globally, only about 14% of patients achieve BP control to systolic BP <140 mm Hg and diastolic BP 60%) require two or more drugs to achieve BP control, yet poor adherence to therapy is a major barrier to achieving this control. Fixed‐dose combinations (FDCs) of BP‐lowering drugs are one means to improve BP control through greater adherence and efficacy, with favorable safety and cost profiles. The authors present a review of the supporting data from a successful application to the World Health Organization (WHO) for the inclusion of FDCs of two BP‐lowering drugs on the 21st WHO Essential Medicines List. The authors discuss the efficacy and safety of FDCs of two BP‐lowering drugs for the management of hypertension in adults, relevant hypertension guideline recommendations, and the estimated cost of such therapies.Keywords
This publication has 57 references indexed in Scilit:
- Economic impact of switching to fixed-dose combination therapy for Japanese hypertensive patients: a retrospective cost analysisBMC Health Services Research, 2013
- Single-Pill vs Free-Equivalent Combination Therapies for Hypertension: A Meta-Analysis of Health Care Costs and AdherenceThe Journal of Clinical Hypertension, 2011
- Management of hypertension: summary of NICE guidanceBMJ, 2011
- Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the Systolic Hypertension in Europe trialJournal Of Hypertension, 2010
- Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive AgentsHypertension, 2010
- Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesBMJ, 2009
- A Simplified Approach to the Treatment of Uncomplicated HypertensionHypertension, 2009
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Hydrochlorothiazide Versus ChlorthalidoneHypertension, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003